Article Details

Analysts See $-0.54 EPS for KalVista Pharmaceuticals, Inc. (KALV); Applied Dna Sciences (APDN ...

Retrieved on: 2019-11-23 22:47:18

Tags for this article:

Click the tags to see associated articles and topics

Analysts See $-0.54 EPS for KalVista Pharmaceuticals, Inc. (KALV); Applied Dna Sciences (APDN .... View article details on hiswai:

Excerpt

<div><b>Applied Dna Sciences</b> Inc (APDN) investors sentiment decreased to 0.57 in Q2 2019. It's down -0.43, from 1 in 2019Q1. The ratio dived, as 4 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up